Pneumococcal conjugate second or third-dose vaccines (PCVc) immunizati in United States
United States: Pneumococcal conjugate second or third-dose vaccines (PCVc) immunizati was 84.0% in 2025. ▼ Falling
Pneumococcal conjugate second or third-dose vaccines (PCVc) immunizati in United States, 2008–2025
Source: World Health Organization, Global Health Observatory.
Analysis
In 2025, pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati in United States stood at 84.0%.
The figure is down 9.7% over ten years.
Over the whole period, pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati in United States peaked at 94.0% in 2011 and was at its lowest, 82.0%, in 2020.
United States ranks 102nd of 194 countries on this measure, in the middle of the range.
The long-run direction has been consistently falling across the 18 years of available data.
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 93.0% | 93.0% | 93.0% | 2 |
| 2010s | 92.6% | 92.0% | 94.0% | 10 |
| 2020s | 83.3% | 82.0% | 84.0% | 6 |
Countries ranked near United States
More health data for United States
- Heat deaths vs projected death rates 1,069 (2090)
- Un projection of annual infant deaths 4,015 (2100)
- Deaths in armed conflicts by region 0 (2026)
- Deaths in armed conflicts by country 0 (2026)
- Age dependency ratio 55.0% (2025)
- Population, male 50.2% (2025)
- Population, male 171.74 million (2025)
- Age population, age 13, female, interpolated 2.05 million (2025)
- Age population, age 12, male, interpolated 2.16 million (2025)
- Population, female 49.8% (2025)
Frequently asked questions
- What is pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati in United States?
- Pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati in United States was 84.0% in 2025, according to World Health Organization, Global Health Observatory.
- What is the highest pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati recorded in United States?
- The highest recorded value was 94.0% in 2011.
- What is the lowest pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati recorded in United States?
- The lowest recorded value was 82.0% in 2020.
- How does United States rank for pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati?
- United States ranks 102nd out of 194 countries with data for 2025.
- Is pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati rising or falling in United States?
- Over the last ten years it is down 9.7%. The long-run trend across the full record is falling.
- Where does this United States data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 18 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).